What do systematic reviews say?

Rituximab vs placebo or control

Rituximab may leads to higher adverse effects: moderate to severe Infusion reactions compared with placebo or control (low certainty).

• Non‐corticosteroid immunosuppressive medications for steroid‐sensitive nephrotic syndrome in children 2020 · Cochrane Headline outcomes only
  RR 5.83 [1.34, 25.29]
  4 studies · 252 participants
  Low